1. The Phosphocreatine System: How Creatine Actually Works
Adenosine triphosphate (ATP) is the universal currency of cellular energy. Every muscular contraction, every nerve impulse, every active ion pump runs on it. The problem: your cells can only store a few seconds of ATP at maximum effort. This is where the phosphocreatine (PCr) system becomes critical.
Creatine is stored in muscle primarily as phosphocreatine — roughly 60–70% of total muscle creatine exists in this phosphorylated form. When ATP is hydrolyzed to ADP during high-intensity effort, the enzyme creatine kinase rapidly re-phosphorylates ADP back to ATP by stripping the phosphate group from PCr. This reaction occurs in milliseconds, bridging the gap between the immediate ATP store (depleted in ~2 seconds) and the slower glycolytic and oxidative systems that take 10–30 seconds to fully engage.
Supplemental creatine elevates total muscle creatine and PCr content by 20–40% above unsupplemented baseline (Harris et al., 1992, Clinical Science). The practical consequence: more phosphocreatine available per sprint, per set, per explosive effort — and faster PCr resynthesis between efforts. This is the primary mechanism behind every performance benefit associated with creatine.
PCr donates its phosphate to ADP → ATP via creatine kinase. More PCr in muscle = more ATP buffered per bout, faster resynthesis between bouts. Dietary creatine (from meat, fish) saturates roughly 60–70% of muscle creatine stores; supplementation pushes stores to near-maximum capacity.
Vegetarians and vegans maintain baseline creatine stores entirely through endogenous synthesis (from glycine, arginine, methionine in the liver and kidneys), but this synthesis rate cannot match the intake an omnivore gets from diet. Muscle creatine concentrations in plant-based individuals average 10–15% lower than omnivores, making the relative ergogenic response to supplementation larger in this population (Burke et al., 2003, International Journal of Sport Nutrition and Exercise Metabolism).
2. Strength, Power & Muscle Mass: What the Evidence Actually Shows
Creatine's ergogenic effect is most consistent in activities lasting 10–30 seconds — the domain of phosphocreatine-dependent energy metabolism. But the downstream effects on chronic training adaptations extend far beyond acute sprint performance.
A 2003 meta-analysis by Lemon and colleagues in the Journal of Strength and Conditioning Research pooled 22 placebo-controlled trials and found creatine supplementation increased maximum strength by a weighted average of 8% and maximum power output by 14% compared to placebo. A 2012 Cochrane-style systematic review (Lanhers et al.) covering resistance-trained populations found consistent improvements in 1-rep-max bench press and squat across the majority of included trials.
For lean body mass, a meta-analysis by Lemon (2000) and a more recent analysis by Lanhers et al. (2017, European Journal of Sport Science) both confirm approximately +1.37 kg additional lean mass gain over 4–12 weeks of supplementation paired with resistance training, vs resistance training plus placebo. The mechanism here is indirect: more phosphocreatine available per set allows higher training volume (more reps at higher loads), and this additional mechanical stimulus drives greater protein synthesis signaling through mTORC1 pathways. There is also a direct cell-volumizing effect — creatine is an osmolyte that draws water intracellularly — which may itself stimulate anabolic signaling.
The effect size is meaningful and durable. Unlike many ergogenic claims that evaporate under rigorous scrutiny, creatine's muscle and strength benefits replicate across dozens of independent labs, different populations, and varying protocols. The 2017 International Society of Sports Nutrition position stand called creatine monohydrate "the most effective ergogenic nutritional supplement currently available to athletes."
3. Brain Creatine: Cognitive Performance, Depression & TBI
Creatine is not just a muscle supplement. The brain is a metabolically expensive organ — comprising 2% of body weight but consuming 20% of resting energy expenditure. Neural tissue expresses creatine kinase and maintains its own creatine/PCr pool to buffer ATP during rapid firing and demanding cognitive tasks.
Cognitive performance under stress: A seminal study by Watanabe et al. (2002, Psychopharmacology) found that 8 weeks of creatine supplementation (8g/day) significantly improved cognitive performance on tasks requiring mental effort and reduced mental fatigue in humans. A 2007 study by Rae et al. (Proceedings of the Royal Society B) randomized vegetarians to creatine or placebo and found significant improvements in working memory and fluid intelligence — populations with lower baseline brain creatine showed the largest gains.
Depression: A growing body of research implicates impaired brain energy metabolism in depressive disorders. A 2012 pilot RCT (Lyoo et al., American Journal of Psychiatry) found that 5g/day creatine added to SSRI treatment significantly accelerated and enhanced antidepressant response in women with major depressive disorder at 2, 4, and 8 weeks compared to SSRI alone. A 2021 review (Kious et al.) published in Bipolar Disorders outlined the mechanistic rationale and called for larger trials.
Traumatic brain injury (TBI): Pediatric TBI trials are particularly compelling. Sakellaris et al. (2008, Journal of Child Neurology) found that children with TBI who received creatine supplementation for 6 months showed significantly reduced duration of post-traumatic amnesia, reduced incidence of headache and dizziness, and better cognitive outcomes versus placebo. The proposed mechanism: creatine helps maintain ATP homeostasis in metabolically compromised neural tissue post-injury.
Aging brain: Brain creatine declines with age alongside muscle creatine. A 2021 systematic review by Roschel et al. (Nutrients) covering 9 trials in older adults found creatine supplementation significantly improved cognitive performance, particularly tasks of memory and processing speed, compared to placebo. Effect sizes were larger in cognitively stressed or sleep-deprived individuals — consistent with creatine's role as an energy buffer under demand.
4. Loading Protocol vs. Steady 5g/Day — and Creatine HCl vs. Monohydrate
The fastest way to saturate muscle creatine stores is the classic loading protocol: 20g/day divided into 4 doses of 5g, taken for 5–7 days. This approach achieves near-maximal muscle saturation within one week (Greenhaff et al., 1994, Clinical Science). After the loading phase, 3–5g/day maintains saturation.
The alternative — 3–5g/day from the outset — achieves the same terminal muscle creatine concentration. It just takes 3–4 weeks to get there rather than one week. If you are not preparing for a competition or time-sensitive goal, the slow approach is equally effective and avoids the transient gastrointestinal discomfort some users report during high-dose loading.
Creatine HCl vs. monohydrate: Creatine hydrochloride is marketed on the claim of greater solubility in water and therefore better absorption at lower doses — allowing "skip the loading phase" and reduced GI distress. The solubility argument is technically true: creatine HCl dissolves more readily in water than monohydrate. The clinical relevance is not established. No published head-to-head RCT has demonstrated that creatine HCl produces superior muscle creatine saturation, performance outcomes, or body composition changes compared to creatine monohydrate at equivalent doses. Monohydrate has 500+ studies behind it; creatine HCl has a handful. Monohydrate is also substantially cheaper per gram of actual creatine delivered. The ISSN position stand explicitly recommends monohydrate as the reference standard. Until HCl accumulates equivalent evidence, it represents a premium price for unproven differentiation.
5. Kidney Safety, Long-Term Use & Contraindications
No supplement topic generates more unfounded concern than creatine and kidney function. This concern traces to a misunderstanding of creatinine — a metabolic byproduct of creatine degradation that is used clinically as a marker of glomerular filtration rate (GFR). Supplemental creatine increases serum creatinine concentrations because more creatine is available to spontaneously cyclize into creatinine. This does not reflect impaired kidney function — it reflects higher creatine throughput.
The clinical evidence is unambiguous. A 2019 systematic review by Gualano et al. (Medicine & Science in Sports & Exercise), covering studies of up to 5 years duration in healthy individuals, found no adverse effect of creatine supplementation on kidney function measured by true GFR markers (cystatin C, inulin clearance). A 2021 study in older adults (Candow et al.) confirmed no renal adverse effects over 3 years of continuous use. The ISSN's position stand states: "There is no scientific evidence that the short- or long-term use of creatine monohydrate has any detrimental effects on otherwise healthy individuals."
The one genuine contraindication: individuals with pre-existing kidney disease. In this population, the kidneys may already be struggling to clear creatinine, and increasing creatine throughput can push serum creatinine into ranges that are harder to interpret clinically. Anyone with chronic kidney disease should consult a nephrologist before supplementing. For everyone else, including athletes, older adults, and adolescents, the safety record is exceptionally clean.
Weight gain: Creatine supplementation causes an initial body weight increase of 0.5–2 kg in the first week of loading. This is intracellular water retention — creatine is an osmolyte that draws water into muscle cells. This is not fat, and it is not edema. It is functionally inert for most purposes, though athletes competing in weight-class sports should account for it.
| Outcome | Effect Size / Finding | Key Reference |
|---|---|---|
| Muscle PCr content | +20–40% above baseline | Harris et al., 1992 (Clin Sci) |
| Maximal strength (1RM) | +8% vs placebo | Lemon et al. meta-analysis, 2003 (JSCR) |
| Peak power output | +14% vs placebo | Lemon et al. meta-analysis, 2003 |
| Lean body mass gain | +1.37 kg vs placebo (4–12 weeks RT) | Lanhers et al., 2017 (EJSS) |
| Working memory (vegetarians) | Significant improvement vs placebo | Rae et al., 2007 (Proc R Soc B) |
| Depression (adjunct to SSRI) | Accelerated + enhanced response | Lyoo et al., 2012 (Am J Psychiatry) |
| Cognitive function (older adults) | Significant memory + processing speed gains | Roschel et al., 2021 (Nutrients) |
| TBI outcomes (children) | Reduced PTA duration, fewer symptoms | Sakellaris et al., 2008 (J Child Neurol) |
| Kidney function (healthy adults) | No adverse effect (up to 5 years) | Gualano et al., 2019 (Med Sci Sports Exerc) |
Creatine monohydrate is the single most evidence-supported performance supplement available. It increases muscle phosphocreatine stores, amplifies strength and power outputs, drives additional lean mass with resistance training, supports brain energy metabolism across multiple domains, and has an exceptional long-term safety profile in healthy individuals. Take 5g/day. Use monohydrate. Stay consistent. Nothing else is required.